Literature DB >> 34259858

Three-dimensional mapping of neurofibrillary tangle burden in the human medial temporal lobe.

Paul A Yushkevich1, Mónica Muñoz López2, María Mercedes Iñiguez de Onzoño Martin2, Ranjit Ittyerah1, Sydney Lim1, Sadhana Ravikumar1, Madigan L Bedard1, Stephen Pickup1, Weixia Liu1, Jiancong Wang1, Ling Yu Hung1, Jade Lasserve1, Nicolas Vergnet1, Long Xie1, Mengjin Dong1, Salena Cui3, Lauren McCollum3, John L Robinson4, Theresa Schuck4, Robin de Flores5, Murray Grossman3, M Dylan Tisdall1, Karthik Prabhakaran3, Gabor Mizsei1, Sandhitsu R Das3, Emilio Artacho-Pérula2, Marı'a Del Mar Arroyo Jiménez2, Marı'a Pilar Marcos Raba2, Francisco Javier Molina Romero2, Sandra Cebada Sánchez2, José Carlos Delgado González2, Carlos de la Rosa-Prieto2, Marta Córcoles Parada2, Edward B Lee4, John Q Trojanowski4, Daniel T Ohm3, Laura E M Wisse6, David A Wolk3, David J Irwin3, Ricardo Insausti2.   

Abstract

Tau protein neurofibrillary tangles are closely linked to neuronal/synaptic loss and cognitive decline in Alzheimer's disease and related dementias. Our knowledge of the pattern of neurofibrillary tangle progression in the human brain, critical to the development of imaging biomarkers and interpretation of in vivo imaging studies in Alzheimer's disease, is based on conventional two-dimensional histology studies that only sample the brain sparsely. To address this limitation, ex vivo MRI and dense serial histological imaging in 18 human medial temporal lobe specimens (age 75.3 ± 11.4 years, range 45 to 93) were used to construct three-dimensional quantitative maps of neurofibrillary tangle burden in the medial temporal lobe at individual and group levels. Group-level maps were obtained in the space of an in vivo brain template, and neurofibrillary tangles were measured in specific anatomical regions defined in this template. Three-dimensional maps of neurofibrillary tangle burden revealed significant variation along the anterior-posterior axis. While early neurofibrillary tangle pathology is thought to be confined to the transentorhinal region, we found similar levels of burden in this region and other medial temporal lobe subregions, including amygdala, temporopolar cortex, and subiculum/cornu ammonis 1 hippocampal subfields. Overall, the three-dimensional maps of neurofibrillary tangle burden presented here provide more complete information about the distribution of this neurodegenerative pathology in the region of the cortex where it first emerges in Alzheimer's disease, and may help inform the field about the patterns of pathology spread, as well as support development and validation of neuroimaging biomarkers.
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s disease; medial temporal lobe; neurodegeneration; neurofibrillary tangles

Mesh:

Year:  2021        PMID: 34259858      PMCID: PMC8783607          DOI: 10.1093/brain/awab262

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   15.255


  55 in total

1.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Authors:  Bradley T Hyman; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Maria C Carrillo; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; Bill Thies; John Q Trojanowski; Harry V Vinters; Thomas J Montine
Journal:  Alzheimers Dement       Date:  2012-01       Impact factor: 21.566

2.  Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.

Authors:  Heiko Braak; Dietmar R Thal; Estifanos Ghebremedhin; Kelly Del Tredici
Journal:  J Neuropathol Exp Neurol       Date:  2011-11       Impact factor: 3.685

3.  Automated volumetry and regional thickness analysis of hippocampal subfields and medial temporal cortical structures in mild cognitive impairment.

Authors:  Paul A Yushkevich; John B Pluta; Hongzhi Wang; Long Xie; Song-Lin Ding; Eske C Gertje; Lauren Mancuso; Daria Kliot; Sandhitsu R Das; David A Wolk
Journal:  Hum Brain Mapp       Date:  2014-09-02       Impact factor: 5.038

4.  Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.

Authors:  Adam J Schwarz; Peng Yu; Bradley B Miller; Sergey Shcherbinin; James Dickson; Michael Navitsky; Abhinay D Joshi; Michael D Devous; Mark S Mintun
Journal:  Brain       Date:  2016-03-02       Impact factor: 13.501

5.  Unbiased diffeomorphic atlas construction for computational anatomy.

Authors:  S Joshi; Brad Davis; Matthieu Jomier; Guido Gerig
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

6.  Familiarity-based memory as an early cognitive marker of preclinical and prodromal AD.

Authors:  David A Wolk; Lauren Mancuso; Daria Kliot; Steven E Arnold; Bradford C Dickerson
Journal:  Neuropsychologia       Date:  2013-03-06       Impact factor: 3.139

7.  Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons.

Authors:  Julie A Schneider; Patricia A Boyle; Zoe Arvanitakis; Julia L Bienias; David A Bennett
Journal:  Ann Neurol       Date:  2007-07       Impact factor: 10.422

8.  Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD.

Authors:  John L Robinson; Ning Yan; Carrie Caswell; Sharon X Xie; EunRan Suh; Vivianna M Van Deerlin; Garrett Gibbons; David J Irwin; Murray Grossman; Edward B Lee; Virginia M-Y Lee; Bruce Miller; John Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  2020-03-01       Impact factor: 3.685

9.  A multi-modal parcellation of human cerebral cortex.

Authors:  Timothy S Coalson; Emma C Robinson; Carl D Hacker; Matthew F Glasser; John Harwell; Essa Yacoub; Kamil Ugurbil; Jesper Andersson; Christian F Beckmann; Mark Jenkinson; Stephen M Smith; David C Van Essen
Journal:  Nature       Date:  2016-07-20       Impact factor: 49.962

10.  Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).

Authors:  Garrett S Gibbons; Soo-Jung Kim; John L Robinson; Lakshmi Changolkar; David J Irwin; Leslie M Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol Commun       Date:  2019-03-04       Impact factor: 7.801

View more
  6 in total

1.  Robust joint registration of multiple stains and MRI for multimodal 3D histology reconstruction: Application to the Allen human brain atlas.

Authors:  Adrià Casamitjana; Marco Lorenzi; Sebastiano Ferraris; Loïc Peter; Marc Modat; Allison Stevens; Bruce Fischl; Tom Vercauteren; Juan Eugenio Iglesias
Journal:  Med Image Anal       Date:  2021-10-16       Impact factor: 8.545

2.  Deep learning for Alzheimer's disease: Mapping large-scale histological tau protein for neuroimaging biomarker validation.

Authors:  Daniela Ushizima; Yuheng Chen; Maryana Alegro; Dulce Ovando; Rana Eser; WingHung Lee; Kinson Poon; Anubhav Shankar; Namrata Kantamneni; Shruti Satrawada; Edson Amaro Junior; Helmut Heinsen; Duygu Tosun; Lea T Grinberg
Journal:  Neuroimage       Date:  2021-12-20       Impact factor: 7.400

3.  Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer's Disease.

Authors:  Josué Llamas-Rodríguez; Jan Oltmer; Douglas N Greve; Emily Williams; Natalya Slepneva; Ruopeng Wang; Samantha Champion; Melanie Lang-Orsini; Bruce Fischl; Matthew P Frosch; André J W van der Kouwe; Jean C Augustinack
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

4.  Ex vivo MRI atlas of the human medial temporal lobe: characterizing neurodegeneration due to tau pathology.

Authors:  Sadhana Ravikumar; Laura E M Wisse; Sydney Lim; Ranjit Ittyerah; Long Xie; Madigan L Bedard; Sandhitsu R Das; Edward B Lee; M Dylan Tisdall; Karthik Prabhakaran; Jacqueline Lane; John A Detre; Gabor Mizsei; John Q Trojanowski; John L Robinson; Theresa Schuck; Murray Grossman; Emilio Artacho-Pérula; Maria Mercedes Iñiguez de Onzoño Martin; María Del Mar Arroyo Jiménez; Monica Muñoz; Francisco Javier Molina Romero; Maria Del Pilar Marcos Rabal; Sandra Cebada Sánchez; José Carlos Delgado González; Carlos de la Rosa Prieto; Marta Córcoles Parada; David J Irwin; David A Wolk; Ricardo Insausti; Paul A Yushkevich
Journal:  Acta Neuropathol Commun       Date:  2021-10-24       Impact factor: 7.801

Review 5.  Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer's Disease and Other Tauopathies.

Authors:  Cinzia Maschio; Ruiqing Ni
Journal:  Front Aging Neurosci       Date:  2022-04-22       Impact factor: 5.702

6.  Structural progression of Alzheimer's disease over decades: the MRI staging scheme.

Authors:  Vincent Planche; José V Manjon; Boris Mansencal; Enrique Lanuza; Thomas Tourdias; Gwenaëlle Catheline; Pierrick Coupé
Journal:  Brain Commun       Date:  2022-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.